Cite
MLA Citation
Amy L. Lightner et al.. “A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis.” Colorectal disease, vol. 24, 2022, pp. 1358–1370. http://access.bl.uk/ark:/81055/vdc_100170365529.0x000020